How Assura became just what the doctor ordered

When Simon Laffin, Assura’s chairman announced his retirement in March, he left the company transformed. Once burdened with unsuccessful investments, unhappy shareholders and an inability to raise cash, Assura prospered as a primary care investor under Laffin’s six-year tenure. Its market cap rocketed from £200m to £1.4bn and it entered the FTSE 250 in December […]